NASDAQ •
Healthcare •
Medical Devices •
Quote as of 09/11/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,806.07 mln
Float86.13 mln
Earnings Date10/22/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.13
Reliable
Relative Strength
10
/ 100
Significantly lagging
Debt / Equity
0.69
Moderate leverage
Pre-Tax Margin
-22%
Deeply loss-making
ROE
-43.69
Deeply negative
Business Description
NovoCure is a medical company focused on fighting cancer through a technology called Tumor Treating Fields, which uses electrical fields to slow or stop the growth of solid tumors. The company sells several devices under the Optune brand name and is actively running clinical trials across a range of cancer types, including lung, brain, pancreatic, and ovarian cancer. Founded in 2000 and based in Switzerland, NovoCure operates across the United States, Europe, Japan, and Greater China.
